CSPC Ouyi Pharmaceutical Co., Ltd.
66
13
15
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
3.0%
2 terminated/withdrawn out of 66 trials
80.0%
-6.5% vs industry average
24%
16 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (66)
Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.
Role: lead
Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)
Role: collaborator
A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMD
Role: lead
A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes
Role: lead
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
Role: collaborator
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer
Role: collaborator
JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma
Role: collaborator
A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma
Role: collaborator
Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients
Role: lead
GVM±R in Patients With Relapsed or Refractory Aggressive NHL
Role: collaborator
A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder
Role: lead
A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis
Role: lead
Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of First Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study
Role: collaborator
A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL
Role: collaborator
A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus
Role: lead
Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.
Role: collaborator
Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer
Role: lead
Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance
Role: lead
A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients
Role: lead
Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer
Role: lead